These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36574352)
21. Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis. Wu XD; Ye XY; Liu XY; Lin Y; Lin X; Li YY; Ye BH; Sun JC Ann Med; 2024 Dec; 56(1):2389470. PubMed ID: 39126262 [TBL] [Abstract][Full Text] [Related]
22. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. Rader DJ; Davidson MH; Caplan RJ; Pears JS Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340 [TBL] [Abstract][Full Text] [Related]
23. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease. Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632 [TBL] [Abstract][Full Text] [Related]
24. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Bays HE; Davidson M; Jones MR; Abby SL Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026 [TBL] [Abstract][Full Text] [Related]
25. Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis. Siddiqui MS; Parmar D; Sheikh F; Sarin SK; Cisneros L; Gawrieh S; Momin T; Duseja A; Sanyal AJ Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2597-2605.e2. PubMed ID: 36731585 [TBL] [Abstract][Full Text] [Related]
26. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials. Winkler K; Ablethauser CB; Gimpelewicz C; Bortolini M; Isaacsohn JL Clin Ther; 2007 Sep; 29(9):1987-2000. PubMed ID: 18035198 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials. Gaba P; Christiansen EH; Nielsen PH; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Stone GW; Sabik JF; Sabatine MS; Holm NR; Bergmark BA JAMA Cardiol; 2023 Jul; 8(7):631-639. PubMed ID: 37256598 [TBL] [Abstract][Full Text] [Related]
29. ECLIPSES: Early initiation of sodium glucose cotransporter-2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery. Makortoff L; Then KL; Dutchak M; Lin M; Youngson E; Harten C Pharmacotherapy; 2024 Nov; 44(11):841-850. PubMed ID: 39460440 [TBL] [Abstract][Full Text] [Related]
30. Dyslipidaemia in patients with chronic kidney disease - a neglected cardiovascular risk factor. Essop MR; Seedat F; Raal FJ S Afr Med J; 2023 Nov; 113(11):35-40. PubMed ID: 38525632 [TBL] [Abstract][Full Text] [Related]
31. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice. Sabouret P; Puymirat E; Kownator S; Abdennbi K; Lebeau F; Meltz M; Angoulvant D; Schiele F Panminerva Med; 2023 Jun; 65(2):244-249. PubMed ID: 36222543 [TBL] [Abstract][Full Text] [Related]
32. Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japan - A Retrospective Database Analysis. Umeda T; Hayashi A; Harada A; Okuyama K; Baxter CA; Tokita S; Teramoto T Circ J; 2018 May; 82(6):1605-1613. PubMed ID: 29628458 [TBL] [Abstract][Full Text] [Related]
33. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313 [TBL] [Abstract][Full Text] [Related]
34. Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age. Fabin N; Cenko E; Bergami M; Yoon J; Vadalà G; Mendieta G; Kedev S; Kostov J; Vavlukis M; Vraynko E; Miličić D; Vasiljevic Z; Zdravkovic M; Badimon L; Galassi AR; Manfrini O; Bugiardini R Cardiovasc Res; 2024 Dec; 120(16):2064-2077. PubMed ID: 39196713 [TBL] [Abstract][Full Text] [Related]
35. Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry. Navar AM; Shah NP; Shrader P; Thomas LE; Ahmad Z; Allred C; Chamberlain AM; Chrischilles EA; Dhalwani N; Effron MB; Hayek S; Jones LK; Kalich B; Shapiro MD; Wójcik C; Peterson ED Am Heart J; 2025 Jan; 279():107-117. PubMed ID: 38972336 [TBL] [Abstract][Full Text] [Related]
36. Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry. Kayıkcioglu M; Başaran Ö; Doğan V; Mert KU; Mert GÖ; Özdemir İH; Rencüzoğulları İ; Karadeniz FÖ; Tekinalp M; Aşkın L; Demirelli S; Gencer E; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Cinier G; Akay KH; Pekel N; Utku Şenol ; Demir V; İnci S; Derviş E; Özlek B; Özlek E; Çelik O; Çil C; Biteker M J Clin Lipidol; 2023; 17(6):732-742. PubMed ID: 38072583 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effectiveness of newer glucose-lowering agents, with and without baseline lipid-lowering therapy in type 2 diabetes: A systematic meta-analysis of cardiovascular outcome trials and real-world evidence. Kunutsor SK; Seidu BS; Seidu S Prim Care Diabetes; 2024 Dec; 18(6):589-598. PubMed ID: 39366881 [TBL] [Abstract][Full Text] [Related]
38. Temporal trends in the treatment and outcome of nonagenarians with acute coronary syndrome. Losin I; Giladi E; Arow Z; Hilu R; Ovdat T; Assali A; Pereg D Coron Artery Dis; 2025 Jan; 36(1):65-69. PubMed ID: 39324985 [TBL] [Abstract][Full Text] [Related]
39. Biomarker diagnostics of endothelial dysfunction in patients with acute coronary syndrome and non-alcoholic fatty liver disease. Matiy VV; Rishko MV; Rosola TF; Hadzheha VM; Stan MP; Tsoka SA Wiad Lek; 2024; 77(10):1857-1862. PubMed ID: 39661874 [TBL] [Abstract][Full Text] [Related]
40. Coronary microevaginations characterize culprit plaques and their inflammatory microenvironment in a subtype of acute coronary syndrome with intact fibrous cap: results from the prospective translational OPTICO-ACS study. Seppelt C; Abdelwahed YS; Meteva D; Nelles G; Stähli BE; Erbay A; Kränkel N; Sieronski L; Skurk C; Haghikia A; Sinning D; Dreger H; Knebel F; Trippel TD; Krisper M; Gerhardt T; Rai H; Klotsche J; Joner M; Landmesser U; Leistner DM Eur Heart J Cardiovasc Imaging; 2024 Jan; 25(2):175-184. PubMed ID: 37395586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]